A French multiple sclerosis sufferer Sunday became the first disabled person to skydive over Mount Everest, successfully completing his landing before being taken to hospital as a precaution.
Oct 27, 2013
0
0
A multiple sclerosis sufferer hoping to become the first disabled person to skydive over Mount Everest says he wants his feat of daring to send "a message of hope" to others with the disease.
Oct 26, 2013
0
0
Over the course of the disease, multiple sclerosis is very often combined with a deteriorating memory and attention deficits. Researchers at the University Department of Radiology and Nuclear Medicine at the MedUni Vienna ...
Oct 14, 2013
0
0
According to new research out of Queen's University, an active lifestyle has many benefits for adults living with multiple sclerosis. Based on that research, Amy Latimer-Cheung (School of Kinesiology and Health Studies) has ...
Oct 11, 2013
0
0
A study led by Dr. Anthony Traboulsee of the University of British Columbia and Vancouver Coastal Health to see whether narrowing of the veins from the brain to the heart could be a cause of multiple sclerosis has found that ...
Oct 8, 2013
0
0
Multiple sclerosis is a debilitating condition that involves the degeneration of myelin—the fatty tissue that insulates nerve fibers and helps them to conduct impulses. This process, called demyelination, can lead to deficits ...
Oct 4, 2013
0
0
Scientists of the International Multiple Sclerosis Genetics Consortium (IMSGC) have identified an additional 48 genetic variants influencing the risk of developing multiple sclerosis. This work nearly doubles the number of ...
Sep 30, 2013
0
0
The number of people being diagnosed with multiple sclerosis in the UK is falling but the population of those living with the disease is growing as patients are living longer, a new study at the University of Dundee has found.
Sep 27, 2013
0
0
Researchers at A*STAR's Singapore Immunology Network (SIgN) have discovered a new mechanism involving p53, the famous tumour suppressor, to fight against aggressive cancers. This strategy works by sabotaging the ability of ...
Sep 18, 2013
0
0
A transformational new treatment for multiple sclerosis (MS) - the result of over three decades of research in Cambridge - was approved today by the EU agency responsible for regulating new drugs.
Sep 18, 2013
0
0
